Gartisertib-d8

SI-7580

Gartisertib-d₈, >98% (HPLC)

CAS No. : [1792214-00-6]

Synonyms : VX-803-d₈; M-4344-d₈; ATR inhibitor 2-d₈

IUPAC Name : 2-Amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl-d₈)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Gartisertib‑d₈ is a deuterium‑labelled version of Gartisertib, an ATP‑competitive ATR inhibitor with picomolar affinity and potent suppression of Chk1 phosphorylation. The labelled analog is commonly used in bioanalytical and PK studies supporting ATR‑targeted drug development in antitumor research.

References : Zenke T. F. et al.: Cancer Res 79 (13), 369, 2019; Gorecki L. et al.: Pharmacol. Ther., 107518, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.